Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

We are very pleased to inform you that Dr. Marc A. Gauthier has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Early Career Investigator Award, acknowledging his outstanding contributions to our Society...

Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...

We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...

CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...

Genetically tailored human mesenchymal stem cells MSC are studied extensively to develop cell-based therapies for bone defects...

Glioblastoma comprises more than 50 of all gliomas which is the most frequent type of brain tumor. 1 Current treatment strategies for this cancer includes surgical resection, radiotherapy, and chemotherapy...

There are currently very few FDA-approved bioresorbable materials for drug delivery in tissue engineering...

Current therapies with tyrosine kinase inhibitors such as Imatinib against Chronic Myeloid Leukemia CML inhibit production of 99 of fast-dividing cells, which are mostly the ones that remain in suspension through out the circulation system...

The Willerth Lab differentiates human induced pluripotent stem cells hiPSCs into functional neurons for drug screening and therapeutics see https www...